The DOI matches its Crossref record; 71 of the 75 references it cites were found in a registry or an index.
Serotonin receptors in the human brain—IV. Autoradiographic mapping of serotonin-2 receptors
Abstract
The anatomical distribution of serotonin-2 receptors in the human brain was studied by light microscopic autoradiography, using [3H]ketanserin as a ligand. The receptor densities were quantified by microdensitometry with the aid of a computer-assisted image-analysis system. A heterogeneous distribution of serotonin-2 receptor densities was found in the human brain. Very high concentrations were localized over layers III and V of several cortical areas, including the frontal, parietal, temporal and occipital lobes, the anterogenual cortex and the entorhinal area, as well as in the corpus mamillare of the hypothalamus. The claustrum, nucleus lateralis of the amygdala and some cortical layers also presented a high density of serotonin-2 receptors. Intermediate concentrations were found over the hippocampus, the caudatus, putamen and accumbens nuclei, and some nuclei of the amygdala, among other structures. Areas such as the thalamus, brain stem, cerebellum and spinal cord contained, in general, only low to very low densities of serotonin-2 receptors. A very high level of non-specific binding, which was not displaceable by any serotonin-2 compound, was found in some areas of the human brain, including the caudatus and putamen nuclei, the substantia nigra and the raphé nuclei. The distribution of serotonin-2 receptors in the human brain described herein is discussed in relation to the distribution of serotonergic innervation, the central effects which have been proposed to be serotonin-2-mediated, and the neuropathological characteristics of the diseases where a modification in the number of serotonin-2 receptors has been reported.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A similar pattern of 5-HT2A receptor expression has been shown in human post-mortem tissue using both autoradiography (211) and in situ hybridization (212).”
From Psychedelics and Other Psychoplastogens for Treating Mental Illness. (2021) · cites this paper as [211]
Citations
Cites
Dahlstroem, A., & Fuxé, K. (1964) · PubMed · Cited by 5,133
A PROPOSED MECHANISM OF EMOTION
PAPEZ, J. W. (1937) · Archives of Neurology And Psychiatry · doi:10.1001/archneurpsyc.1937.02260220069003 · Cited by 3,563
Steinbusch, H. W. M. (1981) · Neuroscience · doi:10.1016/0306-4522(81)90146-9 · Cited by 2,415
Molecular pathology of schizophrenia: more than one disease process?
Crow, T. J. (1980) · BMJ · doi:10.1136/bmj.280.6207.66 · Cited by 1,862
Pazos, Á., & Palacios, J. M. (1985) · Brain Research · doi:10.1016/0006-8993(85)90856-x · Cited by 1,855
Self-citationPeroutka, S. J., & Snyder, S. H. (1979) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13812-1 · Cited by 1,363
Neurobiology of the hippocampus
Rawlins, J. N. P. (1984) · Neuroscience · doi:10.1016/0306-4522(84)90113-1 · Cited by 1,097
Long-Term Antidepressant Treatment Decreases Spiroperidol-Labeled Serotonin Receptor Binding
Peroutka, S. J., & Snyder, S. H. (1980) · Science · doi:10.1126/science.6251550 · Cited by 837
Pazos, Á., Cortés, R., & Palacios, J. M. (1985) · Brain Research · doi:10.1016/0006-8993(85)90857-1 · Cited by 824
Self-citationA new method for receptor autoradiography: [3H]Opioid receptors in rat brain
Young, W. S., & Kuhar, M. J. (1979) · Brain Research · doi:10.1016/0006-8993(79)90442-6 · Cited by 797
Research works printed but not linked: 4
- Blackshear, 1982, Serotonin receptors sensitivity after acute and chronic treatment with mianserin, J. Pharmac. exp. Ther., 221, 303
- Braak, 1980, Architectonic of the human telencephalic cortex, Vol. 4
- Harrison-Read, 1984, Noradrenergic and other strategies for devising new drug treatments of schizophrenia, Trends pharmac. Sci., 5, 139
- Leysen, 1982, [3H]Ketanserin (R 41 468), a selective3H-ligand for serotonin2 receptor binding sites, Molec. Pharmac., 21, 301
Cited by
Sorted by citations
Items 301–355 of 355
Kundu, R., Mondal, S., Kapadia, A., Banerjee, A. A., Kucherak, O. A., Klymchenko, A. S., Koushika, S. P., Venkatramani, R., Vaidya, V. A., & Datta, A. (2025) · Chemical Science · doi:10.1039/d5sc01306b · Cited by 5
History of psychedelic drug science and molecular pharmacology
Nichols, D. E., & Nichols, C. D. (2025) · International review of neurobiology · doi:10.1016/bs.irn.2025.02.001 · Cited by 5
Functional Organization of Dorsal Horn Interneurons
Willis, W. D., & Coggeshall, R. E. (2004) · Springer eBooks · doi:10.1007/978-1-4615-0035-3_7 · Cited by 5
Blanckaert, P., Burvenich, I. J. G., Staelens, L., Dierckx, R. A., & Slegers, G. (2004) · Applied Radiation and Isotopes · doi:10.1016/j.apradiso.2004.10.008 · Cited by 5
Chapter 5 Receptor localization in the human hypothalamus
Palacios, J. M., Probst, A., & Mengod, G. (1992) · Progress in brain research · doi:10.1016/s0079-6123(08)64563-x · Cited by 5
Self-citationThe central antihypertensive action of 5-hydroxytryptamine: The location of site of action
Coote, J. H. (1990) · Springer eBooks · doi:10.1007/978-94-009-0479-8_19 · Cited by 5
The Making of the 5-HT2C Receptor
Palacios, J. M., Pazos, Á., & Hoyer, D. (2010) · The Receptors · doi:10.1007/978-1-60761-941-3_1 · Cited by 4
Self-citation5-HT2A Receptors in the Basal Ganglia
Miguélez, C., Morera-Herreras, T., & Deurwaerdère, P. D. (2018) · Springer eBooks · doi:10.1007/978-3-319-70474-6_12 · Cited by 2
Li, H. Q., Xu, J. Y., Gao, Y., & Jin, L. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.09.030 · Cited by 4
Pérez-Santos, I., García‐Cabezas, M. Á., & Cavada, C. (2023) · Brain Structure and Function · doi:10.1007/s00429-023-02619-w · Cited by 5
Adriaens, A., Polis, I., Vermeire, S. T., Waelbers, T., Croubels, S., Duchateau, L., Dorpe, S. V., Eersels, J. L. H., Spiegeleer, B. M. J. D., & Peremans, K. Y. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.03.004 · Cited by 4
Powell, K. R., & Dykstra, L. A. (1996) · Psychopharmacology · doi:10.1007/bf02246409 · Cited by 4
Alberts, G. L., Chio, C. L., Im, W. B., & Slightom, J. L. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705058 · Cited by 4
Yu, X., Eid, Y., Jama, M., Pham, D., Ahmed, M., attar, M. S., Samiuddin, Z., & Barakat, K. (2024) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2024.108842 · Cited by 3
Kuckertz, A., Zhao, L., Kedo, O., Amunts, K., & Palomero‐Gallagher, N. (2025) · The Journal of Comparative Neurology · doi:10.1002/cne.70068 · Cited by 3
Dörfel, R. P., Arenas‐Gomez, J. M., Svarer, C., Ganz, M., Knudsen, G. M., Svensson, J. E., & Plavén‐Sigray, P. (2024) · GeroScience · doi:10.1007/s11357-024-01148-6 · Cited by 3
Mediators of the Nervous System Kinds Characteristic
Bon, E. I. (2023) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2023.48.007692 · Cited by 3
Serotonin receptor imaging by 18F-PET
Billard, T., Liger, F., & Verdurand, M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812733-9.00013-1 · Cited by 3
The Role of Serotonin on Attentional Processes and Executive Functioning: Focus on 5-HT2C Receptors
Tsaltas, E., & Boulougouris, V. (2010) · The Receptors · doi:10.1007/978-1-60761-941-3_23 · Cited by 2
Mechanisms of upper airway hypotonia
Kubin, L. K., & Davies, R. O. (2011) · Informa Healthcare eBooks · doi:10.3109/9781420020885.004 · Cited by 2
Claudi, F., Scoccia, L., Giorgioni, G., Marucci, G., Stefano, A. D., Gessi, S., Siniscalchi, A., & Borea, P. A. (1998) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(98)80029-9 · Cited by 2
Hsiao, Y., Fonseca, M. A., Tiemroth, A. S., Vasquez, E. J., & Gomez, A. M. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.16.633439 · Cited by 2
Class A GPCR: Serotonin Receptors
Grinde, E., & Herrick‐Davis, K. (2017) · Springer eBooks · doi:10.1007/978-3-319-60174-8_6 · Cited by 1
Lazzaretti, M., Mandolini, G. M., Altamura, A. C., & Brambilla, P. (2018) · Springer eBooks · doi:10.1007/978-3-319-75124-5_2 · Cited by 1
Lasch, A., Schweikert, T., Dora, E., Kolb, T., Schurig, H. L., & Walther, A. (2023) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/a-2046-5202 · Cited by 1
Dickenson, A. H. (1988) · Progress in brain research · doi:10.1016/s0079-6123(08)62793-4 · Cited by 1
Atypical Antipsychotic Drugs: Mechanism of Action
Meltzer, H. Y. (2007) · Wiley eBooks · doi:10.1002/9780470101001.hcn034 · Cited by 1
Khasabov, S. G., & Tamarova, Z. A. (1990) · Neurophysiology · doi:10.1007/bf01058223 · Cited by 1
Bildliche Darstellung von Neurotransmitterinteraktionen in vivo mittels PET
Smith, G. S., Dewey, S. L., Brodie, J. D., Bartlett, E. J., Simkowitz, P., Riedel, R., Fujita, H., Cancro, R., & Wolf, A. P. (1995) · Springer eBooks · doi:10.1007/978-3-642-79738-5_7 · Cited by 1
Gray, J. A., & Roth, B. L. (2007) · Wiley eBooks · doi:10.1002/9780470101001.hcn008 · Cited by 2
Nyberg, S., Nordström, A., Halldin, C., & Farde, L. (1995) · Springer eBooks · doi:10.1007/978-94-011-0429-6_8
Peremans, K. Y., Audenaert, K., Otte, A., van Bree, H., van Heeringen, K., & Dierckx, R. A. J. O. (2004) · Springer eBooks · doi:10.1007/978-3-642-18773-5_10
Meert, T. F., & Leysen, J. E. (1991) · European Neuropsychopharmacology · doi:10.1016/0924-977x(91)90488-g
Ángel, L.-V. M., Gutiérrez-Guzmán, B. E., Cervantes, M., & Olvera‐Cortés, M. E. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-941-3_24
Anti Leishmanial Activities of Some Antidepressant Drugs and Antifungal Drugs.
Trivedi, S., Lodhi, G. N., Doifode, C. A., & Raut, H. I. (2017) · Journal of Advance Research in Pharmacy & Biological Science · doi:10.53555/nnpbs.v3i4.697
Faull, K. F. (1992) · Springer eBooks · doi:10.1007/978-1-4899-1173-5_5
Joyce, J. N. (1994) · Neuropsychopharmacology · doi:10.1038/npp.1994.62
Molecular mechanisms underlying cannabis-induced risk of psychosis
Unzueta‐Larrinaga, P., Callado, L. F., & Urigüen, L. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823490-7.00004-6
Anti Leishmanial Activities of Some Antidepressant Drugs And Antifungal Drugs
Trivedi, S., Lodhi, G. N., Doifode, C. A., & Raut, H. I. (2017) · Journal of Advance Research in Business Management and Accounting · doi:10.53555/nnbma.v3i4.487
Barakat, K., Yu, X., Eid, Y., Jama, M., Pham, D., Ahmed, M., & Attar, M. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4758294
Jacobs, J. T., Maior, R. S., Waguespack, H. F., Campos-Rodríguez, C., Málková, L., & Forcelli, P. A. (2024) · Psychopharmacology · doi:10.1007/s00213-024-06651-4
Lasch, A., Schweikert, T., Dora, E., Kolb, T., Schurig, H. L., & Walther, A. (2025) · Nervenheilkunde · doi:10.1055/a-2517-1621
Psychedelic agents for treatment-resistant depression
Gukasyan, N., & Griffiths, R. R. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824067-0.00014-1
Candidate gene studies of suicidal behavior-2: in relation to serotonergic polymorphisms
Kundu, S. R., & Sarkar, J. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33112-1.00007-0
Localization of 5-HT receptors in the mammalian cortex
Santana, N., de Almeida, J., Mengod, G., & Artigas, F. (2008) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8561-3_5
Scheggi, S., Braccagni, G., Branca, C., & Bortolato, M. (2026) · Aggression and Violent Behavior · doi:10.1016/j.avb.2026.102139
Pratlong, M. (2014) · theses.fr (ABES) · doi:10.70675/02dafa47zd1cfz49e6z86a9zb57e2f9d693f
Kim, S. J., Ibrahimy, A., Constantinescu, C. C., Hoye, J., Searle, G. E., Slifstein, M., Rabiner, E. A., & Morris, E. D. (2026) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x261438226
Bhagavan, C., Carter, O. L., Nielsen, G., Berlowitz, D. J., Issak, S., Braat, S., Zaloumis, S. G., Attard, Z., Oliver, G., Mayne, D., et al. (2026) · CNS Drugs · doi:10.1007/s40263-026-01326-4 · Cited by 2
Burstein, E. S., Sandiego, C., Raether, B., Feng, X., Dirks, B., Darwish, M., Zhang, P., Russell, D. S., Rabiner, E. A., & Pathak, S. (2026) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.70096
de Paula, C. C., Vicentini, A. B., Guerra, L. T. L., Maekawa, R. M., Reis, J. A. S., Villanova, B., Gomes, C. C., Bellucci, T., Rossi, G. N., Bouso, J. C., et al. (2026) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000002267
Bedeutung des serotoninergen Systems für die Pathophysiologie der Migräne
Limmroth, V., & Diener, H. (1994) · Springer eBooks · doi:10.1007/978-3-642-93522-0_13
Metadata
- Authors
- Pazos, A., Probst, A., & Palacios, J. M.
- Affiliations
- University of Basel (CH)
- Sandoz Group AG (Switzerland) (CH)
- Corresponding author
- Palacios, J.M.
- ORCID
- Palacios, J.M.
- Venue
- Neuroscience
- Publisher
- Elsevier BV
- Published
- 1987-04
- Volume
- 21
- Issue
- 1
- Pages
- 123-139
- ISSN
- 0306-4522 (ISSN-L)
- OpenAlex
- W4319425390
- Cited by
- 355
- References
- 75
- Citations by year
- 2026: 6 · 2025: 7 · 2024: 7 · 2023: 6 · 2022: 6 · 2021: 6 · 2020: 3 · 2019: 2 · 2018: 9 · 2017: 14 · 2016: 6 · 2015: 9 · 2014: 10 · 2013: 6 · 2012: 4
- FWCI
- 4.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neuroscience (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- serotonin 2 receptor, human brain, receptor distribution, entorhinal area, hippocampus, basal ganglia, substantia nigra, raphe nuclei, non-specific binding, serotonergic innervation, neurodegenerative diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review